Purity
Seagate grows a variety of roma tomatoes, that has not been genetically modified, and that is well-adapted to the local climate and altitude of their farm. No chemicals are used on either the farm or in the Seagate factory for growing or processing these tomatoes. The principle fertilizer used on the Seagate farm is dried fish. The finished tomato concentrate powder is 100% pure, free of fillers and excipients, and packed in vegetable capsules.
Benefits
Seagate 60 Tomatoes is a 100:1 freeze-dried concentration of whole organic tomatoes, containing between 2-15 mg lycopene/capsule (actual results depends upon test method and lab) along with all the other valuable phytonutrients that are naturally-occurring in tomatoes. Tomato consumption provides dietary support for maintaining cardiovascular and prostate health. 60 Tomatoes offers convenience for people who do not eat or are unable to prepare a daily serving of fresh tomatoes.
Processing
Each batch of tomatoes is processed on the same day they are harvested from Seagate’s organic farm. Seagate processes their tomatoes in their state-of-the-art manufacturing plant, containing stainless-steel presses, freeze-dryers, and cryogenic grinders. Seagate uses NO chemicals or solvents in this or in any of their products.
Lycopene Controversy
Few health food “manufacturers” actually grow or process their own raw materials. Most of the vitamin companies that market lycopene purchase their ingredients from raw material brokers or foreign suppliers. Some of these suppliers use toxic solvents such as ethyl acetate which may concentrate lycopene but also eliminate the other phytonutrients available from the tomato. Residuals of this chemical (up to 50 ppm) may still be found in their lycopene capsules even though they are not listed on the product labels. Seagate concentrates the entire tomato, opting not to separate out individual phytonutrients such as lycopene because scientific study has shown that whole tomatoes offer better protection than lycopene supplements alone(1).
References
(1) Journal of the National Cancer Institute 2003 (Vol. 95, No. 21:1578-86)
|
1-800-418-4842
